Search for: "NOVARTIS CONSUMER HEALTH, INC" Results 21 - 40 of 78
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
28 Jan 2013, 4:35 am by Rebecca Tushnet
”  The court analogized to the “Night Time Strength” case, Novartis Consumer Health, Inc. v. [read post]
12 Mar 2012, 5:41 pm by FDABlog HPM
Novartis Pharmaceuticals Corp., No. 33-av-00001 (D.N.J., Mar. 7, 2012) (Complaint) Plumbers and Pipefitters Local 572 Health and Welfare Fund v. [read post]
28 Jan 2012, 7:45 am by Jon L. Gelman
 Related articlesThe Bay Citizen: Nursing Homes in California Confront Pharmacists' Errors (nytimes.com) Workers Compensation on Drugs - Tenn Supreme Court Allows Fatal Case to Proceed (workers-compensation.blogspot.com) Surgery Common for Medicare Patients in Final Year of Life (workers-compensation.blogspot.com) The Complex World of Workers' Compensation and Pharmaceutical Benefits (workers-compensation.blogspot.com) Novartis Consumer Health Inc. [read post]
11 Jan 2012, 8:39 am by Peter N. Freiberg
Novartis Consumer Health, Inc. announced on January 8, 2012 that it was voluntarily recalling all lots of select bottle packaging configurations of Excedrin and NoDoz with expiration dates of December 20, 2014 or earlier, as well as Bufferin and Gas-X prevention products with expiration dates of December 20, 2013 or earlier. [read post]
10 Jan 2012, 3:22 pm by info@thomasjhenrylaw.com
Novartis Consumer Health, Inc. has issued a recall on several popular over-the-counter medications including Excedrin, NoDoz, Bufferin, and Gas-X due to a possible manufacturing mix-up. [read post]
10 Jan 2012, 11:06 am
Novartis Consumer Health, Inc. recently announced the voluntary recall of select bottles of Excedrin, NoDoz, Bufferin and Gas-X. [read post]
10 Jan 2012, 11:06 am
Novartis Consumer Health, Inc. recently announced the voluntary recall of select bottles of Excedrin, NoDoz, Bufferin and Gas-X. [read post]
1 Dec 2011, 3:58 am by Lawrence B. Ebert
Bloomberg also reported: Pfizer has struck deals with companies including Catalyst Health Solutions Inc. and Coventry Health Care Inc. to prevent generic Lipitor from reaching some patients until the end of May 2012. [read post]
14 Aug 2011, 11:13 am
To establish a false advertising claim, Pernod must prove the following under Warner-Lambert v Breathasure (2000), that:Bacardi made false or misleading statements as to his own product [or another's];there is actual deception or at least a tendency to deceive a substantial portion of the intended audience;the deception is material in that it is likely to influence purchasing decisions;the advertised goods travel in interstate commerce; andthere is a likelihood of injury to the Pernod in terms… [read post]
18 Jul 2011, 6:12 am by Rebecca Tushnet
Precision argued that PCM couldn’t “salvage wholly unsubstantiated statements with arguments cobbled together after the statements were made,” citing Novartis Consumer Health, Inc. v. [read post]
2 Jun 2011, 12:46 pm by Bexis
Novartis Pharmaceuticals Corp., 2011 WL 1533467, at *9 (E.D.N.Y. [read post]
13 Apr 2011, 2:29 pm by Rebecca Tushnet
’” Guidance didn’t do any testing, therefore this (implicit) claim was false because it was utterly unsubstantiated (citing Novartis Consumer Health, Inc. v. [read post]